Boston Consulting Group

GPT-Rosalind: Accelerating Life Sciences & Drug Discovery with AI

OpenAI unveils GPT-Rosalind, a new AI model purpose-built for life sciences research, accelerating drug discovery, biology, and translational medicine through advanced reasoning and tool integration.